tirzepatide first dose side effects Dosing 20 Possible Tirzepatide Side Effects

The main difference between semaglutide and other similar GLP-1 receptor agonists medications, such as Mounjaro (tirzepatide) and Trulicity (dulaglutide), which are circulating on the internet for their weight loss potential, is that Mounjaro and Trulicity are not yet approved by the FDA for medical weight loss in non-diabetic patients

The guidelines were also published in Pediatrics, an AAP journal, which has its own industry relationships

Your medical team will track your progress, monitor for side effects, and make adjustments to your dosage or treatment length as needed

Semaglutide Side Effects (Well-Established) Common (from STEP trial data): Nausea (44%) Diarrhea (30%) Vomiting (24%) Constipation (24%) Abdominal pain (20%) Headache (14%) Serious but rare: Pancreatitis Gallbladder events (increased with rapid weight loss) Thyroid C-cell tumors (boxed warning based on animal studies) Most GI side effects are dose-dependent and improve with continued use